Maryland Capital Advisors Inc. Abb Vie Inc. Transaction History
Maryland Capital Advisors Inc.
- $220 Million
- Q1 2025
A detailed history of Maryland Capital Advisors Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Maryland Capital Advisors Inc. holds 300 shares of ABBV stock, worth $55,833. This represents 0.03% of its overall portfolio holdings.
Number of Shares
300
Previous 300
-0.0%
Holding current value
$55,833
Previous $53,000
16.98%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,263Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$32.4 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$14.9 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.2 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.66 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $329B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...